Rating History for Hepion Pharma (HEPA) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/7/2023 | Kumaraguru Raja | Downgrade | Hold (Buy) |
N/A (N/A) |
3.24 (0.32) |
-90.12% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/7/2023 | Kumaraguru Raja | Downgrade | Hold (Buy) |
N/A (N/A) |
3.24 (0.32) |
-90.12% | Details |
![]() |
|||||||
![]() |
|||||||